FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296096124> ?p ?o ?g. }

• W4296096124 endingPage "1918" @default.
• W4296096124 startingPage "1918" @default.
• W4296096124 abstract "(1) Background: Numerous oral drugs exhibit limited bioavailability due to their poor solubility and poor intestinal permeability. The smartFilm technology is an innovative approach that improves the drug aqueous solubility via incorporating the drug in an amorphous state into a cellulose-based matrix, i.e., paper. smartFilms can be transformed into a free-flowing physical form (i.e., paper granules) that can be compressed into tablets with optimum physico-chemical and pharmaceutical properties. The aim of this study was to investigate if smartFilm tablets are suitable for improved oral delivery of poorly water-soluble drugs. (2) Methods: Curcumin is a poorly soluble drug with low intestinal permeability and was used for the production of curcumin-loaded smartFilms. The curcumin-loaded smartFilms were transferred into smartFilm granules which were then compressed into curcumin-loaded smartFilm tablets. The tablets were characterized regarding their physico-chemical and pharmaceutical properties, and the intestinal permeability of curcumin was determined with the ex vivo porcine intestinal model. The ex vivo intestinal permeability of curcumin from the smartFilm tablets was compared to a physical mixture of curcumin and paper and to a classical and to an innovative commercial product, respectively. (3) Results: The produced curcumin-loaded smartFilm tablets fulfilled the European Pharmacopoeia requirements, incorporated curcumin in amorphous state within the cellulose matrix and exhibited an enhanced dissolution rate. The ex vivo intestinal permeation data were shown to correlate to the in vitro dissolution data. The ex vivo intestinal permeation of curcumin from the smartFilm tablets was about two-fold higher when compared to the physical mixture and the classical commercial product. No differences in the ex vivo bioavailability were found between the smartFilm tablets and the innovative commercial product. (4) Conclusions: smartFilm tablets are a cost-effective and industrially feasible formulation approach for the formulation of poorly water-soluble drugs, i.e., BCS class II and IV drugs." @default.
• W4296096124 created "2022-09-17" @default.
• W4296096124 creator A5014244381 @default.
• W4296096124 creator A5047129430 @default.
• W4296096124 creator A5081665828 @default.
• W4296096124 date "2022-09-10" @default.
• W4296096124 modified "2023-09-26" @default.
• W4296096124 title "SmartFilm Tablets for Improved Oral Delivery of Poorly Soluble Drugs" @default.
• W4296096124 cites W1947743855 @default.
• W4296096124 cites W1963486780 @default.
• W4296096124 cites W1970254739 @default.
• W4296096124 cites W1991067170 @default.
• W4296096124 cites W2011707100 @default.
• W4296096124 cites W2028895013 @default.
• W4296096124 cites W2031967005 @default.
• W4296096124 cites W2034163151 @default.
• W4296096124 cites W2044376814 @default.
• W4296096124 cites W2065181822 @default.
• W4296096124 cites W2068820688 @default.
• W4296096124 cites W2095329582 @default.
• W4296096124 cites W2099540110 @default.
• W4296096124 cites W2516286426 @default.
• W4296096124 cites W2765561039 @default.
• W4296096124 cites W2766083858 @default.
• W4296096124 cites W2769848125 @default.
• W4296096124 cites W2770729810 @default.
• W4296096124 cites W2807283644 @default.
• W4296096124 cites W2921550223 @default.
• W4296096124 cites W2955461563 @default.
• W4296096124 cites W2968213237 @default.
• W4296096124 cites W2990987568 @default.
• W4296096124 cites W3012649388 @default.
• W4296096124 cites W3015967600 @default.
• W4296096124 cites W3021491219 @default.
• W4296096124 cites W3091622220 @default.
• W4296096124 cites W3092120380 @default.
• W4296096124 cites W3112503641 @default.
• W4296096124 cites W3136762864 @default.
• W4296096124 cites W3140534739 @default.
• W4296096124 cites W3161949976 @default.
• W4296096124 cites W3192837620 @default.
• W4296096124 cites W3200367505 @default.
• W4296096124 cites W3206880052 @default.
• W4296096124 cites W4200468858 @default.
• W4296096124 cites W4220878382 @default.
• W4296096124 cites W4223417659 @default.
• W4296096124 cites W4280528784 @default.
• W4296096124 cites W4293769736 @default.
• W4296096124 doi "https://doi.org/10.3390/pharmaceutics14091918" @default.
• W4296096124 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36145666" @default.
• W4296096124 hasPublicationYear "2022" @default.
• W4296096124 type Work @default.
• W4296096124 citedByCount "3" @default.
• W4296096124 countsByYear W42960961242023 @default.
• W4296096124 crossrefType "journal-article" @default.
• W4296096124 hasAuthorship W4296096124A5014244381 @default.
• W4296096124 hasAuthorship W4296096124A5047129430 @default.
• W4296096124 hasAuthorship W4296096124A5081665828 @default.
• W4296096124 hasBestOaLocation W42960961241 @default.
• W4296096124 hasConcept C14029885 @default.
• W4296096124 hasConcept C150903083 @default.
• W4296096124 hasConcept C155574463 @default.
• W4296096124 hasConcept C178790620 @default.
• W4296096124 hasConcept C181389837 @default.
• W4296096124 hasConcept C185592680 @default.
• W4296096124 hasConcept C202751555 @default.
• W4296096124 hasConcept C203014093 @default.
• W4296096124 hasConcept C207001950 @default.
• W4296096124 hasConcept C26291073 @default.
• W4296096124 hasConcept C2778250585 @default.
• W4296096124 hasConcept C2779820397 @default.
• W4296096124 hasConcept C2780035454 @default.
• W4296096124 hasConcept C2781071285 @default.
• W4296096124 hasConcept C2781430271 @default.
• W4296096124 hasConcept C41625074 @default.
• W4296096124 hasConcept C43617362 @default.
• W4296096124 hasConcept C50670333 @default.
• W4296096124 hasConcept C55493867 @default.
• W4296096124 hasConcept C71924100 @default.
• W4296096124 hasConcept C86803240 @default.
• W4296096124 hasConcept C98274493 @default.
• W4296096124 hasConceptScore W4296096124C14029885 @default.
• W4296096124 hasConceptScore W4296096124C150903083 @default.
• W4296096124 hasConceptScore W4296096124C155574463 @default.
• W4296096124 hasConceptScore W4296096124C178790620 @default.
• W4296096124 hasConceptScore W4296096124C181389837 @default.
• W4296096124 hasConceptScore W4296096124C185592680 @default.
• W4296096124 hasConceptScore W4296096124C202751555 @default.
• W4296096124 hasConceptScore W4296096124C203014093 @default.
• W4296096124 hasConceptScore W4296096124C207001950 @default.
• W4296096124 hasConceptScore W4296096124C26291073 @default.
• W4296096124 hasConceptScore W4296096124C2778250585 @default.
• W4296096124 hasConceptScore W4296096124C2779820397 @default.
• W4296096124 hasConceptScore W4296096124C2780035454 @default.
• W4296096124 hasConceptScore W4296096124C2781071285 @default.
• W4296096124 hasConceptScore W4296096124C2781430271 @default.
• W4296096124 hasConceptScore W4296096124C41625074 @default.
• W4296096124 hasConceptScore W4296096124C43617362 @default.

• next